DIN 02470489 — BENLYSTA 200 MG
BENLYSTA is a solution of Belimumab marketed by GLAXOSMITHKLINE INC. The full Belimumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02470489
- Brand name
- BENLYSTA
- Active ingredient
- Belimumab
- Strength
- 200 MG
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- GLAXOSMITHKLINE INC
- Health Canada status
- MARKETED
- Drug class
- BLyS-specific inhibitor (selective immunosuppressant)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Belimumab products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02370050 | BENLYSTA | 120 MG | POWDER FOR SOLUTION | GLAXOSMITHKLINE INC | MARKETED |
| 02370069 | BENLYSTA | 400 MG | POWDER FOR SOLUTION | GLAXOSMITHKLINE INC | MARKETED |